Usefulness of the SAMe-TT2R2 risk score in identifying patients who will do well with vitamin K antagonist therapy in a community-based cohort of patients with non-valvular atrial fibrillation
Date issued
2014Journal title
European Heart Journal
Type of content
Publicación de congreso